Definition:
Osteoporosis is a progressive bone disease in which the bones gradually become
weaker due to loss of minerals. This weakening increases the chance
of fractures with age. More than half of the female population between
the ages of 30-75 is likely to develop this bone disorder. Bone
is a substance that is constantly changing. Throughout our lives
minerals are released from our bones (resorption), and absorbed
back again. Until we reach the age of 20 more bone is produced than
resorbed. By the age of 30 this process begins to reverse. This
process goes mostly undetected until the age of 50 bone density
scans are usually preformed. However, until the bone density test
is done, we usually have no knowledge of the extent bone loss.
Symptoms:
Without knowing the rate of bone loss, there is no accurate way to determine
bone density until a bone density test is performed. Until bone
begin breaking there are no symptoms to this disorder.
Holistic Treatment Plan:
The best treatment is prevention. Making sure that bone is being
replaced closely to the rate at which it is being lost. Just taking
calcium is not enough. Weight bearing exercises, the intake of minerals
like magnesium, manganese, zinc, vitamin C, phosphorus, silica,
and a new compound called Ipriflavone. Ipriflavone is synthesized
from soy and has been shown in over 20 years of testing to greatly
help the body in replacing bone. Ipriflavone is safe, and very effective.
It is one of the ingedients in Osteo-Plus. Knowing the rate of bone
loss is important, so that you can determine how successful you
are doing. There is available a simple urine test, which can measure
the rate of bone resorption. If you are interested in this test
please call my office for details.
References:
Dixon, A. S., Non-Hormonal Treatment of Osteoporosis, British Medical Journal,
Vol.286, No.6370, March 26, 1983; Windsor, A. C. M., Mira, D. P., Loudon, J.M., Staddon,
G. E., The Effect of Whole Bone Extract on 47Ca Absorption in the Elderly, Age and
Aging, 1973,1:230; Nilsen, K. H., Jayson, M., Dixon, A. S., Microcrystalline
Calcium Hydroxyapatite Compound in Corticosteroid treated rheumatoid patients: Controlled
Study, British Medical Journal, 1978.
Disclaimer:
All information given here is for educational purposes only. For a proper diagnosis and
treatment plan you must consult your health care practitioner.
